Search

Sep 26, 2024
Houston Oncology Summit: Oppenheimer analysts Jeff Jones and Jay Olson talk radiopharmaceuticals and antibody-drug conjugates
Jeff Jones notes how radioisotopes are being added to more than just antibodies, and calls out upcoming data from Perspective...

Aug 8, 2024
Oppenheimer analyst Jay Olson joins BiotechTV for Analyst Thursdays and talks obesity and earnings
Jay Olson shares learnings from a physician survey Oppenheimer conducted on obesity, and comments on Viking, Amgen, Madrigal, Acadia,...